Hemoadsorption in Critical Care - It is a Useful or a Harmful Technique?
作者信息
Kovacs Judit
机构信息
Department of Anesthesiology and Intensive Care, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Targu Mures Romania.
出版信息
J Crit Care Med (Targu Mures). 2020 Nov 7;6(4):207-209. doi: 10.2478/jccm-2020-0036. eCollection 2020 Oct.
Abstract
摘要
相似文献
1
Hemoadsorption in Critical Care - It is a Useful or a Harmful Technique?重症监护中的血液吸附——它是一种有用的还是有害的技术？
J Crit Care Med (Targu Mures). 2020 Nov 7;6(4):207-209. doi: 10.2478/jccm-2020-0036. eCollection 2020 Oct.
2
Hemoadsorption in critical care.重症监护中的血液吸附
Ther Apher. 2002 Jun;6(3):189-92. doi: 10.1046/j.1526-0968.2002.00430.x.
3
Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia.血液吸附可清除肿瘤坏死因子、白细胞介素-6和白细胞介素-10，降低核因子-κB与DNA的结合，并改善致死性内毒素血症的短期生存率。
Crit Care Med. 2004 Mar;32(3):801-5. doi: 10.1097/01.ccm.0000114997.39857.69.
4
Hemoadsorption corrects hyperresistinemia and restores anti-bacterial neutrophil function.血液吸附可纠正高抵抗素血症并恢复中性粒细胞的抗菌功能。
Intensive Care Med Exp. 2017 Dec;5(1):36. doi: 10.1186/s40635-017-0150-5. Epub 2017 Aug 4.
5
Hemoadsorption to Reduce Plasma-Free Hemoglobin During Cardiac Surgery: Results of REFRESH I Pilot Study.心脏手术中应用血液吸附降低血浆游离血红蛋白：REFRESH I 研究的初步结果。
Semin Thorac Cardiovasc Surg. 2019 Winter;31(4):783-793. doi: 10.1053/j.semtcvs.2019.05.006. Epub 2019 May 11.
6
Blood purification by nonselective hemoadsorption prevents death after traumatic brain injury and hemorrhagic shock in rats.非选择性血液吸附净化可预防创伤性脑损伤和失血性休克大鼠的死亡。
J Trauma Acute Care Surg. 2018 Dec;85(6):1063-1071. doi: 10.1097/TA.0000000000002069.
7
Alteco endotoxin hemoadsorption in Gram-negative septic shock patients.Alteco内毒素血液吸附在革兰氏阴性脓毒症休克患者中的应用
Indian J Crit Care Med. 2014 Dec;18(12):783-8. doi: 10.4103/0972-5229.146305.
8
Clinical Utility of Extracorporeal Cytokine Hemoadsorption Therapy: A Literature Review.体外细胞因子血液吸附治疗的临床实用性：文献综述。
Blood Purif. 2018;46(4):337-349. doi: 10.1159/000492379. Epub 2018 Sep 3.
9
Hemoadsorption by CytoSorb in septic patients: a case series.细胞吸附剂（CytoSorb）对脓毒症患者的血液吸附：病例系列
Crit Care. 2017 Mar 27;21(1):74. doi: 10.1186/s13054-017-1662-9.
10
Comparison of intraoperative versus intraoperative plus postoperative hemoadsorption therapy in cardiac surgery patients with endocarditis.心脏手术合并心内膜炎患者术中与术中加术后血液吸附疗法的比较。
Int J Artif Organs. 2019 Apr;42(4):194-200. doi: 10.1177/0391398819831301. Epub 2019 Feb 25.
引用本文的文献
1
Pumpless Extracorporeal Hemadsorption Technique (pEHAT): A Proof-of-Concept Animal Study.无泵体外血液吸附技术（pEHAT）：一项概念验证性动物研究。
J Clin Med. 2022 Nov 18;11(22):6815. doi: 10.3390/jcm11226815.
本文引用的文献
1
The haemodynamic effects of oXiris haemofilter in septic shock patients requiring renal support: A single-centre experience.oXiris血液滤过器对需要肾脏支持的感染性休克患者的血流动力学影响：一项单中心经验。
Int J Artif Organs. 2021 Jan;44(1):17-24. doi: 10.1177/0391398820917150. Epub 2020 May 11.
2
Experience with hemoadsorption (CytoSorb) in the management of septic shock patients.血液吸附（CytoSorb）在脓毒性休克患者治疗中的应用经验。
World J Crit Care Med. 2020 Jan 31;9(1):1-12. doi: 10.5492/wjccm.v9.i1.1.
3
Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: A randomized crossover double-blind study.奥昔里斯膜对感染性休克患者内毒素和细胞因子的清除作用：一项随机交叉双盲研究。
PLoS One. 2019 Aug 1;14(8):e0220444. doi: 10.1371/journal.pone.0220444. eCollection 2019.
4
Extracorporeal life support and systemic inflammation.体外生命支持与全身炎症反应
Intensive Care Med Exp. 2019 Jul 25;7(Suppl 1):46. doi: 10.1186/s40635-019-0249-y.
5
Rationale of Hemoadsorption during Extracorporeal Membrane Oxygenation Support.体外膜肺氧合支持期间血液吸附的原理。
Blood Purif. 2019;48(3):203-214. doi: 10.1159/000500015. Epub 2019 May 16.
6
oXiris® Use in Septic Shock: Experience of Two French Centres.oXiris® 在感染性休克中的应用：两个法国中心的经验。
Blood Purif. 2019;47 Suppl 3:1-7. doi: 10.1159/000499510. Epub 2019 Apr 12.
7
Sepsis: The evolution in definition, pathophysiology, and management.脓毒症：定义、病理生理学及管理的演变
SAGE Open Med. 2019 Mar 21;7:2050312119835043. doi: 10.1177/2050312119835043. eCollection 2019.
8
Hemoadsorption therapy in the critically ill: solid base but clinical haze.危重症患者的血液吸附治疗：坚实基础但临床前景不明
Ann Intensive Care. 2019 Jan 31;9(1):22. doi: 10.1186/s13613-019-0491-1.
9
Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls.体外技术治疗脓毒症危重症患者：承诺与陷阱（超出常规血液净化治疗范围）。
Crit Care. 2018 Oct 25;22(1):262. doi: 10.1186/s13054-018-2181-z.
10
Clinical Utility of Extracorporeal Cytokine Hemoadsorption Therapy: A Literature Review.体外细胞因子血液吸附治疗的临床实用性：文献综述。
Blood Purif. 2018;46(4):337-349. doi: 10.1159/000492379. Epub 2018 Sep 3.
Zotero 插件